Sensei Biotherapeutics is developing an innovative pipeline of first-in-class immune activating agents for a broad array of cancers including solid tumors and hematological malignancies. Our therapies benefit from a precision medicine approach that has the potential to identify patients that will benefit most from our therapies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.